GALVANIS

Company Bio

Galvanis is building the next lever in regenerative medicine: bioelectricity. We're starting in an indication that meets orphan designation criteria (corneal defects, PCED) to rapidly gain traction to expand to the massive ophthalmology market, then the broader wound healing market.